Aphasia, Primary Progressive Clinical Trial
Official title:
Trial of Propranolol in Older Adults With Primary Progressive Aphasia
The purpose of this study is to find out how the language of people with Primary Progressive Aphasia is affected by Propranolol. Propranolol is not FDA approved for the treatment of Primary Progressive Aphasia. Propranolol is FDA approved for the treatment of heart conditions such as blood pressure. This research is being done because there are currently no drug treatment options for language impairments and anxiety often experienced by people with Primary Progressive Aphasia.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT02675270 -
Rehabilitation and Prophylaxis of Anomia in Primary Progressive Aphasia
|
N/A | |
| Withdrawn |
NCT03448133 -
rTMS for the Treatment of Primary Progressive Aphasia: A Randomized Controlled Trial
|
N/A | |
| Active, not recruiting |
NCT04937452 -
Dopaminergic Therapy for Frontotemporal Dementia Patients
|
Phase 2 | |
| Recruiting |
NCT05437159 -
Investigating Speech Sequencing in Neurotypical Speakers and Persons With Disordered Speech
|
N/A |